SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $772,297 | -8.7% | 20,249 | -6.2% | 0.02% | -26.7% |
| Q3 2022 | $846,000 | +201.1% | 21,594 | +227.2% | 0.03% | +76.5% |
| Q4 2021 | $281,000 | -60.7% | 6,599 | -73.5% | 0.02% | -67.3% |
| Q1 2020 | $715,000 | +245.4% | 24,897 | +1050.5% | 0.05% | +300.0% |
| Q4 2018 | $207,000 | -58.4% | 2,164 | -38.6% | 0.01% | -64.9% |
| Q3 2018 | $498,000 | -84.3% | 3,523 | -82.6% | 0.04% | -83.1% |
| Q2 2018 | $3,163,000 | +628.8% | 20,205 | +230.8% | 0.22% | +291.1% |
| Q1 2017 | $434,000 | -14.1% | 6,108 | -38.3% | 0.06% | -30.0% |
| Q4 2016 | $505,000 | -38.4% | 9,900 | -44.4% | 0.08% | -56.3% |
| Q3 2016 | $820,000 | -36.7% | 17,800 | -31.0% | 0.18% | +38.6% |
| Q1 2015 | $1,296,000 | – | 25,815 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 181,650 | $15,715,000 | 7.17% |
| GREAT POINT PARTNERS LLC | 454,417 | $39,312,000 | 6.38% |
| ACUTA CAPITAL PARTNERS, LLC | 255,800 | $22,129,000 | 6.02% |
| Integral Health Asset Management, LLC | 195,000 | $16,869,000 | 5.02% |
| DAFNA Capital Management LLC | 181,306 | $15,685,000 | 4.67% |
| Boxer Capital, LLC | 1,094,000 | $94,642,000 | 3.04% |
| Palo Alto Investors LP | 590,200 | $51,058,000 | 2.68% |
| Bellevue Group AG | 1,567,504 | $135,604,000 | 1.55% |
| Aristotle Atlantic Partners, LLC | 160,805 | $13,911,000 | 1.07% |
| JGP Global Gestao de Recursos Ltda. | 2,618 | $226,000 | 0.85% |